4502:TYO
Takeda Pharmaceutical Company
5 665,00 ¥
arrow_downward
-1,99%(-115,00) 1 d.
1. okt., 09:26:24 GMT+9 · JPY
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: 4502…
Atvērt
5 759 ¥
Augsta
5 770 ¥
Zema
5 653 ¥
Tirgus kapitalizācija
9,08 trilj.
Vid. apjoms
4,20 milj.
Apjoms
652,20 tūkst.
Dividende
3,53%
Ceturkšņa dividendes
50 ¥
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 29. sept.
Augstākā 52 ned.
6 033 ¥
Zemākā 52 ned.
4 102 ¥
Peļņa uz vienu akciju
-103 ¥
Apgrozībā esošās akcijas
784,48 milj.
Darbinieku skaits
47 tūkst.
Atvērt
5 759 ¥
Augsta
5 770 ¥
Zema
5 653 ¥
Tirgus kapitalizācija
9,08 trilj.
Vid. apjoms
4,20 milj.
Apjoms
652,20 tūkst.
Dividende
3,53%
Ceturkšņa dividendes
50 ¥
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 29. sept.
Augstākā 52 ned.
6 033 ¥
Zemākā 52 ned.
4 102 ¥
Peļņa uz vienu akciju
-103 ¥
Apgrozībā esošās akcijas
784,48 milj.
Darbinieku skaits
47 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
www.marketscreener.com
·
pirms 1 stundas
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Stock Titan
·
pirms 15 minūtēm
Nasdaq trading is expected to begin Oct. 1 for Chilwa after its share sale was priced.
Bloomberg.com
·
pirms 2 stundām
Asian Stocks Eye Rough Start After US Reversal: Markets Wrap
Investor's Business Daily
·
pirms 28 minūtēm
Dow Jones Futures: Micron Earnings Crush Views, S&P 500 At Critical Level As Treasury Yields Rise
Profils
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Par “Takeda Pharmaceutical Company”
ĢenerāldirektorsChristophe Weber | Christophe Weber
Darbinieki47 tūkst.
Dibināšanas datums1781. gada 12. jūn.
Galvenais birojs-
Sektors-
Tīmekļa vietnetakeda.com